Ramicard

Ramipril BP

Composition : Ramipril 1.25mg, 2.5mg & 5mg Tablet.

Indication : Ramicard is indicated in the treatment of : (1) Mild to severe hypertension, where it may be used alone or in combination with thiazide diuretics. (2) Congestive heart failure. (3) To reduce the risk of stroke, myocardial infarction and death from cardiovascular events in patients with a history of cardiovascular disease. (4) Proteinuric non-diabetic nephropathy.

Dosage and administration :

Dosage of Ramicard must be adjusted according to the patient tolerance and response. Hypertension: For the management of hypertension in adults not receiving a diuretic, the usual initial dose of Ramicard is 1.25 - 2.5 mg once daily. Dosage generally is adjusted no more rapidly than at 2-week intervals. The usual maintenance dosage in adults is 2.5 - 20 mg daily given as a single dose or in 2 divided doses daily. If BP is not controlled with Ramicard alone, a diretic may be added. Congestive heart failure after myocardial infarction: In this case, Ramicard therapy may be initiated as early as 2 days after myocardial infarction. An initial dose of 2.5 mg twice daily is recommended, but if hypotension occurs, dose should be reduced to 1.25 mg twice daily. Therapy is then titrated to a target daily dose of 5 mg twice daily. Prevention of major cardiovascular events: In this case, the recommended dose is 2.5 mg once daily for the first week of therapy and 5 mg once daily for the following 3 weeks; dosage then may be increased, as tolerated, to a maintenance dosage of 10 mg once daily. Dosage in renal impariment: For the patients with hypertension and renal impairment, the recommended initial dose is 1.25 mg Ramicard once daily. Subsequent dosage should be titrated according to individual tolerance and BP response, up to a maximum of 5 mg daily. For the patients with heart failure and renal impairment, the recommended dose is 1.25 mg once daily. The dose may be increased to 1.25 mg twice daily and up to a maximum dose of 2.5 mg twice daily depending upon clinical response and tolerability. Or as directed by registered physician.

Packing : Ramicard-1.25mg tablet : 4 x 14's tablets in blister pack.

Ramicard-2.5mg tablet : 4 x 14's tablets in blister pack.

Ramicard-5mg tablet : 4 x 14's tablets in blister pack.